Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bonus Biogroup ( (IL:BONS) ) just unveiled an announcement.
The District Court of Tel Aviv – Jaffa has approved Bonus Biogroup’s request to extend the realization period for six series of non-tradable warrants until June 1, 2025. This decision allows the company more time to convene meetings with shareholders and warrant holders to approve a two-year extension, potentially impacting the company’s financial strategies and shareholder relations.
More about Bonus Biogroup
Bonus Biogroup operates in the biotechnology industry, focusing on the development and commercialization of innovative biotechnological products. The company’s securities are listed on the Tel Aviv Stock Exchange.
YTD Price Performance: 150.0%
Average Trading Volume: 9,158
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $61.91M
Learn more about BONS stock on TipRanks’ Stock Analysis page.